MARKET INTRODUCTION
Genomic biomarkers are Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA) characteristics used as disease characterization, an indicator of diagnosis, and therapy selection. These biomarkers reflect biological and pathogenic processes and response to therapeutic or other intervention. They are variants in the DNA code that, alone or in combination, enable early detection of disease by predicting its risk and improves patient treatment by monitoring the outcomes.
MARKET DYNAMICS
The rising burden of chronic diseases (cardiovascular diseases, cancer, strokes, and arthritis), high demand for minimally invasive procedures, and technological advancements will spur the demand of the genomic biomarkers market. However, high cost, complex development process, stringent government regulations and lack of standardized means to validate the marker may restraint the growth of the market in the forecasted period. Additionally, development in R&D, and the infrastructure for data sharing and the demand for personalized medicines will boost the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Genomic Biomarkers Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of genomic biomarkers market with detailed market segmentation the area of type, application, and geography. The global genomic biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading genomic biomarkers market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global genomic biomarkers market is segmented on the type, and application. Based on the type, the genomic biomarkers market is segmented into oncology, cardiovascular diseases, neurological diseases, and others. Based on application, the global genomic biomarkers market is segmented into diagnostic and research laboratories, hospitals, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global genomic biomarkers market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genomic biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting genomic biomarkers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the genomic biomarkers market in these regions.
MARKET PLAYERS
The reports cover key developments in the genomic biomarkers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from genomic biomarkers market are anticipated to lucrative growth opportunities in the future with the rising demand for genomic biomarkers in the global market. Below mentioned is the list of few companies engaged in the genomic biomarkers market.
The report also includes the profiles of key genomic biomarkers market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific
- F. Hoffmann-La Roche Ltd
- Aepodia
- Myriad Genetics, Inc
- Eurofins Scientific
- QIAGEN
- Bio-Rad Laboratories, Inc
- Exact Sciences Corporation
- Liquid Genomics, Inc,
- Epigenomics
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genomic Biomarkers Market - By Type
1.3.2 Genomic Biomarkers Market - By Application
1.3.3 Genomic Biomarkers Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENOMIC BIOMARKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENOMIC BIOMARKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENOMIC BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. GENOMIC BIOMARKERS - GLOBAL MARKET OVERVIEW
6.2. GENOMIC BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GENOMIC BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ONCOLOGY
7.3.1. Overview
7.3.2. Oncology Market Forecast and Analysis
7.4. CARDIOVASCULAR DISEASES
7.4.1. Overview
7.4.2. Cardiovascular diseases Market Forecast and Analysis
7.5. NEUROLOGICAL DISEASES
7.5.1. Overview
7.5.2. Neurological diseases Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. GENOMIC BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DIAGNOSTIC AND RESEARCH LABORATORIES
8.3.1. Overview
8.3.2. Diagnostic and Research Laboratories Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GENOMIC BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Genomic Biomarkers Market Overview
9.1.2 North America Genomic Biomarkers Market Forecasts and Analysis
9.1.3 North America Genomic Biomarkers Market Forecasts and Analysis - By Type
9.1.4 North America Genomic Biomarkers Market Forecasts and Analysis - By Application
9.1.5 North America Genomic Biomarkers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Genomic Biomarkers Market
9.1.5.1.1 United States Genomic Biomarkers Market by Type
9.1.5.1.2 United States Genomic Biomarkers Market by Application
9.1.5.2 Canada Genomic Biomarkers Market
9.1.5.2.1 Canada Genomic Biomarkers Market by Type
9.1.5.2.2 Canada Genomic Biomarkers Market by Application
9.1.5.3 Mexico Genomic Biomarkers Market
9.1.5.3.1 Mexico Genomic Biomarkers Market by Type
9.1.5.3.2 Mexico Genomic Biomarkers Market by Application
9.2. EUROPE
9.2.1 Europe Genomic Biomarkers Market Overview
9.2.2 Europe Genomic Biomarkers Market Forecasts and Analysis
9.2.3 Europe Genomic Biomarkers Market Forecasts and Analysis - By Type
9.2.4 Europe Genomic Biomarkers Market Forecasts and Analysis - By Application
9.2.5 Europe Genomic Biomarkers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Genomic Biomarkers Market
9.2.5.1.1 Germany Genomic Biomarkers Market by Type
9.2.5.1.2 Germany Genomic Biomarkers Market by Application
9.2.5.2 France Genomic Biomarkers Market
9.2.5.2.1 France Genomic Biomarkers Market by Type
9.2.5.2.2 France Genomic Biomarkers Market by Application
9.2.5.3 Italy Genomic Biomarkers Market
9.2.5.3.1 Italy Genomic Biomarkers Market by Type
9.2.5.3.2 Italy Genomic Biomarkers Market by Application
9.2.5.4 Spain Genomic Biomarkers Market
9.2.5.4.1 Spain Genomic Biomarkers Market by Type
9.2.5.4.2 Spain Genomic Biomarkers Market by Application
9.2.5.5 United Kingdom Genomic Biomarkers Market
9.2.5.5.1 United Kingdom Genomic Biomarkers Market by Type
9.2.5.5.2 United Kingdom Genomic Biomarkers Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Genomic Biomarkers Market Overview
9.3.2 Asia-Pacific Genomic Biomarkers Market Forecasts and Analysis
9.3.3 Asia-Pacific Genomic Biomarkers Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Genomic Biomarkers Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Genomic Biomarkers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Genomic Biomarkers Market
9.3.5.1.1 Australia Genomic Biomarkers Market by Type
9.3.5.1.2 Australia Genomic Biomarkers Market by Application
9.3.5.2 China Genomic Biomarkers Market
9.3.5.2.1 China Genomic Biomarkers Market by Type
9.3.5.2.2 China Genomic Biomarkers Market by Application
9.3.5.3 India Genomic Biomarkers Market
9.3.5.3.1 India Genomic Biomarkers Market by Type
9.3.5.3.2 India Genomic Biomarkers Market by Application
9.3.5.4 Japan Genomic Biomarkers Market
9.3.5.4.1 Japan Genomic Biomarkers Market by Type
9.3.5.4.2 Japan Genomic Biomarkers Market by Application
9.3.5.5 South Korea Genomic Biomarkers Market
9.3.5.5.1 South Korea Genomic Biomarkers Market by Type
9.3.5.5.2 South Korea Genomic Biomarkers Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Genomic Biomarkers Market Overview
9.4.2 Middle East and Africa Genomic Biomarkers Market Forecasts and Analysis
9.4.3 Middle East and Africa Genomic Biomarkers Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Genomic Biomarkers Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Genomic Biomarkers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Genomic Biomarkers Market
9.4.5.1.1 South Africa Genomic Biomarkers Market by Type
9.4.5.1.2 South Africa Genomic Biomarkers Market by Application
9.4.5.2 Saudi Arabia Genomic Biomarkers Market
9.4.5.2.1 Saudi Arabia Genomic Biomarkers Market by Type
9.4.5.2.2 Saudi Arabia Genomic Biomarkers Market by Application
9.4.5.3 U.A.E Genomic Biomarkers Market
9.4.5.3.1 U.A.E Genomic Biomarkers Market by Type
9.4.5.3.2 U.A.E Genomic Biomarkers Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Genomic Biomarkers Market Overview
9.5.2 South and Central America Genomic Biomarkers Market Forecasts and Analysis
9.5.3 South and Central America Genomic Biomarkers Market Forecasts and Analysis - By Type
9.5.4 South and Central America Genomic Biomarkers Market Forecasts and Analysis - By Application
9.5.5 South and Central America Genomic Biomarkers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Genomic Biomarkers Market
9.5.5.1.1 Brazil Genomic Biomarkers Market by Type
9.5.5.1.2 Brazil Genomic Biomarkers Market by Application
9.5.5.2 Argentina Genomic Biomarkers Market
9.5.5.2.1 Argentina Genomic Biomarkers Market by Type
9.5.5.2.2 Argentina Genomic Biomarkers Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GENOMIC BIOMARKERS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENOMIC BIOMARKERS MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE LTD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AEPODIA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MYRIAD GENETICS, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. EUROFINS SCIENTIFIC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. QIAGEN
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIO-RAD LABORATORIES, INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. EXACT SCIENCES CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LIQUID GENOMICS, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. EPIGENOMICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT PUBLISHERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Thermo Fisher Scientific
2. F. Hoffmann-La Roche Ltd
3. Aepodia
4. Myriad Genetics, Inc
5. Eurofins Scientific
6. QIAGEN
7. Bio-Rad Laboratories, Inc
8. Exact Sciences Corporation
9. Liquid Genomics, Inc,
10. Epigenomics